Friederike Buchholz

ORCID: 0000-0003-1456-0642
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Dementia and Cognitive Impairment Research
  • Functional Brain Connectivity Studies
  • Language Development and Disorders
  • Natural Language Processing Techniques
  • Mental Health Research Topics
  • Neurobiology of Language and Bilingualism
  • Geriatric Care and Nursing Homes
  • Intergenerational Family Dynamics and Caregiving
  • Alzheimer's disease research and treatments
  • Aging, Elder Care, and Social Issues

Charité - Universitätsmedizin Berlin
2022-2023

German Center for Neurodegenerative Diseases
2022-2023

Humboldt-Universität zu Berlin
2022-2023

Freie Universität Berlin
2022-2023

Abstract Background Alzheimer's disease (AD) is often preceded by stages of cognitive impairment, namely subjective decline (SCD) and mild impairment (MCI). While cerebrospinal fluid (CSF) biomarkers are established predictors AD, other non‐invasive candidate include personality traits, anxiety, depression, among others. These offer assessment exhibit changes during AD development preclinical stages. Methods In a cross‐sectional design, we comparatively evaluated the predictive value traits...

10.1002/gps.6007 article EN cc-by International Journal of Geriatric Psychiatry 2023-10-01

Background: Dementia is a priority for global public health. The management of behavioral and psychological symptoms dementia (BPSD) one the highest ongoing challenges needs new approaches. special care unit people with BPSD (SCU-B) viewed in this context as further medical intervention. Aim: study aims to explore SCU-B units order describe their main characteristics relation different implementation contexts, identify replicability, examine social innovation elements promoted by units....

10.3390/ijerph192416913 article EN International Journal of Environmental Research and Public Health 2022-12-16

10.30820/2752-2121-2023-4-77 article DE Trauma Kultur Gesellschaft 2023-01-01

Abstract Background Alzheimer’s disease (AD) is often preceded by stages of cognitive impairment, namely subjective decline (SCD) and mild impairment (MCI). While cerebrospinal fluid (CSF) biomarkers are established predictors AD, other non-invasive candidate include personality traits, anxiety, depression, among others. These offer assessment exhibit changes during AD development preclinical stages. Methods In a cross-sectional design, we comparatively evaluated the predictive value traits...

10.1101/2022.11.30.22282930 preprint EN cc-by medRxiv (Cold Spring Harbor Laboratory) 2022-11-30
Coming Soon ...